InvestorNewsBreaks – Blackbriar Regulatory Services LLC Enters Strategic Partnership with Beard Management Inc.

April 13, 2021 13:19:08

Blackbriar Regulatory Services (“BRS”), a firm that assists domestic and international companies navigate the regulatory landscape to bring their U.S. Food and Drug Administration (“FDA”) regulated product concepts to market, today announced its entry into a multifaceted regulatory services, manufacturing and distribution agreement with Beard Management Inc. According to the update, BRS will become Beard’s exclusive manufacturer and a distributor for the company’s Beard Vape Co and The One brands’ nicotine products and will oversee the FDA pre-market tobacco application (“PMTA”) process for these products going forward. As a part of the new collaboration agreement, Beard will co-brand a range of complimentary PRISM e-liquid products, which are currently awaiting regulatory PMTA approval and being manufactured under license by BRS. “We are honored that Beard, a globally recognized and respected brand, has put their trust in BRS as a key strategic partner moving forward,” said Russ Rogers, CEO of BRS. “Our combination of ISO certified cleanroom production and analytical lab facilities, and industry leading FDA regulatory application team puts us in a position to provide a very compelling value proposition to customers who are making the investment to be in this industry long-term. Beard’s unwavering commitment to high-quality products and regulatory practices makes them a great partner, and we could not be more excited to provide them with a wide array of business solutions to help them ensure that their amazing brand continues to grow and remains a long-term part of this rapidly changing and maturing industry.”

To view the full press release, visit https://ibn.fm/Szma2

About Blackbriar Regulatory Services LLC

Blackbriar Regulatory Services specializes in helping small to mid-sized domestic and international companies navigate the regulatory landscape to bring their U.S. Food and Drug Administration (“FDA”) regulated product concepts to market. Since its inception, BRS has perfected processes in cost-efficient manufacturing, analytical testing, regulatory compliance audits and filings, rigorous project management, packaging design, and product stewardship for international customers from the United States, Europe and Asia. BRS prides itself on speed and flexibility, while never compromising quality or its customers’ confidential information. Learn more at www.bb-rs.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.